Previous Article | Next Article ![]()
Infection and Immunity, January 2006, p. 442-448, Vol. 74, No. 1
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.1.442-448.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Medical Biochemistry and Microbiology, Biomedical Centre, Uppsala University, PO Box 582, Uppsala, Sweden
Received 19 July 2005/ Returned for modification 9 September 2005/ Accepted 13 October 2005
|
|
|---|
|
|
|---|
Variation in gonococcal epitopes assists in immune evasion and specific inhibitory cellular interactions have also been identified. Boulton and Gray-Owen reported that binding of gonococcal opacity proteins (Opa52) to CEACAM1 on primary CD4+ T lymphocytes results in the suppression of cellular activation and proliferation via the immunoreceptor tyrosine inhibitory motif (5). In contrast, other neisserial factors have been shown upregulate the proliferation and activation of immune cells. Gonococcal porin induces the proliferation of T lymphocytes from patients with urogenital gonococcal disease, without inducing proliferation of cells from noninfected patients, and a significant increase in porin-specific interleukin-4 (IL-4)-producing CD4+ and CD8+ T cells have been observed in patients with mucosal gonococcal disease (28). It has also been demonstrated by Levine et al. that the number of CD4+ T cells in vaginal washings from women with acute gonococcal disease is greater than that of uninfected women (16).
Infection by pathogenic Neisseria spp. is initiated by interaction between the type IV pili and cellular receptors including CD46 (14), the complement regulatory protein 3 (8), and I-domain containing integrins (7). Adherence of Neisseria to CD46 is correlated with the expression of the PilC protein, a pilus-associated 110-kDa protein, located at the tip of the pilus fiber, and in the cell membrane (22). However, numerous studies have also shown that the major pilus subunit, PilE, is involved in receptor recognition, with antigenic variant forms of PilE influencing epithelial cell adherence and tissue tropism (11, 20, 23, 32). CD46, which is also a receptor for pathogens other than Neisseria (6, 14, 21, 25, 26), has been observed to impact lymphocyte activation and has the capacity to modulate the activation and proliferation of T lymphocytes in response to T-cell receptor (TCR) cross-linking in vitro (25). Recently, it has also been shown that CD46 is involved in the induction the T-regulatory 1 (Tr1) phenotype of human CD4+ T cells (15).
In the present study we examined the capacity of gonococcal strains with mutations in pilus components to modulate the activity of primary human CD4+ T lymphocytes. We show that bacterial interaction induces the activation and proliferation of cells and that proliferation can be observed with purified pili alone. Gonococcal infection of T cells also stimulates the production of IL-10. These findings provide further evidence that gonococcal pili is an important cellular component modulating T-cell activity in vivo and show that the gonococcal pilus is involved in the induction of signaling events leading to modulation of the CD4+ T-cell response.
|
|
|---|
Cell lines and primary T-cell purification. Human peripheral blood mononuclear cells were purified from buffy coats (Bloodcentralen, Karolinska Hospital) by using Ficoll-Hypaque gradient centrifugation (400 x g, 20 min). CD4+ T cells were isolated by negative selection with a MACS CD4+ T-cell isolation kit (Miltenyi Biotech). The purification efficiency of CD4+ T cells was assessed by examining coexpression of CD3 and CD4 with fluorescein isothiocyanate anti-CD4 and allophycocyanin anti-CD3 (BD Pharmingen). Purified lymphocytes were routinely >90% CD3+ CD4+ as determined by flow cytometry. Cells were maintained in RPMI 1640 containing 10% fetal calf serum and 2 mM L-glutamine at 37°C in 5% CO2 and humidified air.
Adhesion of Neisseria to T cells. Isolated CD4+ T lymphocytes and bacteria were resuspended in cell media, and the cells were infected with bacterial strains for 1 h (37°C, 5% CO2). After incubation the cells were centrifuged at 280 x g, washed five times with media, and lysed with saponin (1%) for 5 min. Serial dilutions were spread on GCB plates and grown overnight, and the CFU were enumerated. The assay was repeated three times with different blood donors.
Lymphocyte activation assay.
Cells were stimulated with recombinant human IL-2 (200 U/ml; Pharmingen) for 48 h before infection or antibody challenge. The cells were washed three times prior to use in the assay to remove the influence of IL-2 in stimulation. TCR stimulation was induced by treatment with 5 µg of mouse anti-human CD3
immunoglobulin G (clone UCHT1; Pharmingen)/ml, and costimulation controls were induced with 5 µg of anti-CD28 (clone CD28.2 Pharmingen) or anti-CD46 Ab-2 (169-1. E4.3; Neomarker)/ml. Bacterial stimulation was induced by infection with a multiplicity of infection (MOI) of 20 of bacteria grown for 18 h on GC agar plates, and gentamicin (50 µg/ml) was added at 2 h postinfection to prevent bacterial overgrowth. CD69 expression was examined by staining 5 x 105 lymphocytes with phycoerythrin-labeled anti-CD69 (BD Pharmingen). A minimum of 10,000 cells from each sample was analyzed by flow cytometry with CellQuest software (Becton Dickinson). Activation conditions were performed and assayed in duplicate, and the data represented are from five separate experiments.
Lymphocyte proliferation assay.
Cells were stimulated with IL-2 and washed as described above. In vitro primary stimulation was carried out in 96-well culture plates with monoclonal antibodies to CD3
and costimulation with antibodies to CD28 or CD46. Purified lymphocytes (5 x 104 cells per well) were incubated with antibodies at 5 µg/ml, bacterial strains at an MOI of 20 or purified pili from all strains at 1 µg/ml, and MS11P+ pili at various concentrations. Two hours after infection gentamicin (50 µg/ml) was added to all wells to prevent bacterial overgrowth. After 3 days of primary stimulation proliferation was monitored by using the XTT Cell Proliferation Kit II (Roche). Each activation condition was performed in triplicate, and the data represented are from three independent experiments.
Cytokine assay. Cells (2 x 105/well) were incubated for 5 days in 96-well plates coated with monoclonal antibodies to CD3 (clone HIT3a; Pharmingen), CD46 and CD28. The antibodies were used at 10 µg/ml. Cells were infected with neisserial strains at an MOI of 20. IL-2 was incubated with cells at a concentration of 200 U/ml. Two hours after infection gentamicin was added to all wells at a final concentration of 50 µg/ml. The secretion of IL-10 and tumor necrosis factor (TNF) in the supernatants was assessed by enzyme linked immunosorbent assays (ELISAs) with kits from Diaclone. Assays were repeated twice in independent experiments with different donors.
Western blotting and silver staining of pili preparations. Bacterial pilus extracts (500 ng) were separated by sodium dodecyl sulfate-12% polyacrylamide electrophoresis and transferred to polyvinylidene difluoride membranes or silver stained by using standard protocols. The membranes were blocked overnight with 5% nonfat dried milk in Tris-buffered saline (0.05 M Tris and 2 M NaCl [pH 7.4]) containing 0.05% Tween 20. PilC was identified by incubation with the K3 antibody that recognizes both PilC1 and PilC2 (polyclonal rabbit antibody diluted 1:5,000). PilE was identified with an antigonococcal PilE antibody (polyclonal rabbit antibody diluted 1:1,000). The Opa proteins were detected with the 4B12/C11 antibody that recognizes all Opa proteins (1) (monoclonal mouse antibody diluted 1:5,000). Incubation with primary antibodies was followed by horseradish peroxidase-conjugated goat anti-rabbit antibody (Bio-Rad; diluted 1:10,000) or by horseradish peroxidase-conjugated goat anti-mouse antibody (Santa Cruz Biotechnologies; diluted 1:10,000). A chemiluminescence kit from Perkin-Elmer Life Sciences was used for detection.
Statistical analysis. Statistical variations were determined by using Student t tests for the adhesion assays, or Kruskal-Wallis tests for nonparametric data in all other tests, with significance accepted at P < 0.05. Blood from numerous donors was analyzed in each assay.
|
|
|---|
![]() View larger version (15K): [in a new window] |
FIG. 1. The adherence of wild-type piliated N. gonorrhoeae MS11P+ and the nonpiliated isogenic mutant MS11P to primary human CD4+ T cells. GC were allowed to adhere to cells for 60 min, and unbound bacteria were removed by washing the cells in multiple centrifugation steps to pellet cells. Infected cells were treated with saponin, serially diluted, and spread on GCB plates. CFU were counted, and the attachment is represented as the percentage of applied bacteria associated with cells.
|
![]() View larger version (16K): [in a new window] |
FIG. 2. Expression of the activation marker CD69 by primary human CD4+ T cells after infection with GC. Purified cells were left unstimulated ( ) or stimulated with antibodies to CD3 ( ) in the presence or absence of antibodies to the known costimulatory molecules CD28 and CD46 or the piliated and nonpiliated MS11 gonococcal strains. Bacteria were added at an MOI of 20, and gentamicin was added at 2 h postinfection to prevent bacterial overgrowth. The percentage of CD69+ cells was determined by staining with phycoerythrin-labeled anti-CD69 antibody and analysis by flow cytometry. Significant increases (P < 0.05) in CD69 levels compared to anti-CD3 treated cells are indicated by a double asterisk. Significance was determined by using a Kruskal-Wallis test.
|
![]() View larger version (15K): [in a new window] |
FIG. 3. Proliferation of human T cells after infection with the piliated and nonpiliated GC. Purified human cells were incubated in 96-well plates with antibodies to CD46 and CD28, as well as with the gonococcal strains in the absence ( ) or presence ( ) of TCR ligation for 3 days. Bacteria were added at an MOI of 20, and gentamicin was added at 2 h postinfection to prevent bacterial overgrowth. Proliferation was determined by using the XTT Cell Proliferation Kit. Significant increases (P < 0.05) in proliferation compared to anti-CD3 treated cells are indicated by a double asterisk. Significance was determined by using a Kruskal-Wallis test.
|
![]() View larger version (25K): [in a new window] |
FIG. 4. T cells stimulated with antibodies to CD3, CD28, and CD46, and/or infected with GC were assayed for IL-10 (A) and TNF (B) production. Assays were conducted both in the presence ( ) or absence ( ) of recombinant IL-2. Purified human cells were incubated with antibodies and GC strains for 5 days, with gentamicin added at 2 h postinfection to prevent bacterial overgrowth, and cytokines in the supernatant were measured by ELISA (Diaclone). Significant reductions (P < 0.05) in cytokine levels compared to control cell treatments are indicated by a single asterisk, while significant cytokine inductions are indicated by a double asterisks. Significance was determined by using a Kruskal-Wallis test.
|
![]() View larger version (31K): [in a new window] |
FIG. 5. The role of the putative adhesive pilus component PilC on the CD4+ T-cell status was determined with the isogenic mutant strains of GC, MW4 (PilC+), and MW7 (PilC). (A) Western blotting of these strains confirmed the expected phenotypes after staining with antibodies to PilE and PilC. A Coomassie blue-stained gel of the two bacterial preparations shows equal loading. (B) The adhesion to T cells was determined and is expressed as the percentage of applied bacteria that associate with cells. (C) The number of activated cells was determined by examination of expression of CD69 after treatment with bacterial strains. Significant increases (P < 0.05) compared to untreated cells are indicated by a single asterisk, and significant increases compared to anti-CD3 treated cells are indicated by a double asterisks. Significance was determined by using a Student's t test for the adhesion assay and a Kruskal-Wallis test for the activation assay. Assays conducted in the absence of TCR ligation are by indicated with black bars and in the presence of TCR ligation are indicated by white bars.
|
![]() View larger version (30K): [in a new window] |
FIG. 6. (A) Pili were purified from the piliated wild-type gonococcal strain MS11P+ and the mutant strains MS11P, MW4 (PilC+), and MW7 (PilC) and analyzed by silver staining of SDS-PAGE. (B) Pili were used to stimulate T cells in the absence (black bars) and presence (white bars) or TCR ligation. (C) The proliferation of cells following infection with various concentrations of pili from the wild-type strain was monitored at 3 days postinfection by using the XTT Cell Proliferation Kit. Significant increases (P < 0.05) in proliferation were determined by using a Kruskal-Wallis test, and significant changes are indicated by an asterisk.
|
|
|
|---|
Several studies have indicated that CD46 is an important signaling factor in T cells. It is able to transduce signals and aggregation on human T cells induces phosphorylation of the adaptor proteins p120CBL, ZAP-70 and linker for activation of T cells (LAT) which regulate TCR signaling, as well as activating ERK, JNK, and p38 (4, 24). Also, TCR-CD46 costimulation strongly promotes T-cell activation and proliferation, and the production of Th1 cytokines, indicating further that CD46 is a potent costimulatory molecule for human T cells (4, 24). Other Neisseria receptors are also likely to have a role in T-cell modulation. It is well known that in addition to mediating adhesion to cell surface and extracellular matrix ligands, integrins generate a diverse array of intracellular signals. In T cells, LFA-1 and several ß1 integrins can provide costimulatory signals for TCR-induced T-cell activation (27, 31), indicating that molecules other than CD46 which act as receptors for gonococci could also be involved in the stimulation of T cells noted in the present study.
We show that binding of Neisseria to T cells induces the activation and proliferation of these cells. The piliated GC strain strongly promoted the activation of cells, and infection also increased the cell culture density by 50% compared to the nonstimulated control. The PilC-expressing strain, MW4, showed a similar effect to the piliated strain, whereas the nonpiliated strain and the PilC deletion mutant, MW7, did not induce activation of T cells, probably due to the lack of interaction with cells since both PilE and PilC are considered important in mediating adhesion to host cells, including T cells (Fig. 1 and 5B).
The importance of the pili in inducing the stimulatory effect is evident from the data showing a dose-dependent proliferative effect of purified MS11P+ pili on cells, as seen in Fig. 6C. This effect was also enhanced by TCR costimulation. At a higher MOI all strains stimulated the activation and proliferation of T cells (data not shown), which is most likely due to the presence of saturating amounts of stimulatory components in the bacterial cell wall, such as lipopolysaccharide and porin. The data shown in Fig. 6 indicate that the effect is mediated by pili, since only the MS11P+ pilus preparation was able to mediate an increase in proliferation of cells. There were no contaminating proteins present in the pilus preparation, as determined by silver staining. However, despite this, it is also possible that other components that were not detectable could be mediating this effect seen with piliated gonococci. Nonetheless, we have shown here that piliation enhances T-cell activation and proliferation, regardless of whether this is mediated by the pilus itself or is due to the act of binding. It is likely that Opa50 also mediates such an effect since Boulton and Gray-Owen previously showed that an Opa50 expressing gonococcal strain also induced T-cell proliferation in the absence of piliation (5).
The costimulation of human CD4+ T cells with antibodies to CD3 and CD46 has been shown to induce a Tr1 cell phenotype in the presence of IL-2 (15). The poor response to gonococcal infection may be due to the induction of Tr1 cells upon CD46 ligation, suppressing the activation of bystander T cells via the induction of IL-10 and other inhibitory cytokines. The finding that piliated gonococci induce IL-10 in the cell culture supernatant suggests a T-cell suppressive effect. This effect is pilus dependent, particularly since treatment with other neisserial components such as gonococcal porin do not induce significant levels of IL-10 (28). The effect however may not necessarily be linked to CD46 binding.
It would be interesting to inhibit binding and cellular activation and proliferation by using antibodies to CD46 and other known adhesins to determine the specificity for this interaction. However, due to the response to CD46 costimulation, it is not possible to use these antibodies in the cell reaction, since addition alone alters cellular responses. Attempts to inhibit the binding of the wild-type GC to epithelial cells using antibodies to CD46 have been unsuccessful and the specificity of an association between pili and CD46 on T cells is therefore difficult to prove.
The pili of gonococci stimulate CD4+ T cells, inducing their activation and proliferation. The expression of pili is also involved in the production of IL-10 by T cells, and the possible induction of cells with a regulatory phenotype may provide further explanation for asymptomatic gonococcal infection. It is likely that a pilus receptor, such as CD46 or integrins, may have a role in this process, although such an involvement has been impossible to elucidate since it is difficult to block interactions using specific antibodies, which modulate T-cell responses themselves. Nevertheless, pili have an important role in the modulation of the T-cell response, and the results shown here indicate that pilus-induced activation and proliferation of T cells overrides the effects of other gonococcal components, excluding Opa, which were not examined in the present study.
The gonococcal mutants were kindly provided by Michael Koomey from the University of Oslo, Oslo, Norway.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»